|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.15 CNY | -1.24% |
|
+1.61% | -4.29% |
| 04-16 | Gan & Lee Pharmaceuticals Gets Nod to Trial GLR1062 Injection | MT |
| 04-15 | Gan & Lee Pharmaceuticals' Subsidiary Doses First Subject for Phase III of GZR33 Injection Trial; Shares Up 3% | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 5.69B | |||||
| 77.02B | |||||
| 59.3B | |||||
| 50.73B | |||||
| 47.29B | |||||
| 26.03B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition